Cleared Traditional

K071103 - HABIB HEXABLATE

K071103 is an FDA 510(k) clearance for HABIB HEXABLATE, manufactured by Emcision , Ltd.. The device is a Class 2 General & Plastic Surgery device with product code GEI cleared through the Traditional 510(k) pathway after a 69-day FDA review.

K071103 · Emcision , Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2007
Decision
69d
Days
Class 2
Risk

K071103 is an FDA 510(k) clearance for the HABIB HEXABLATE. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Emcision , Ltd. (London, Uk, GB). The FDA issued a Cleared decision on June 27, 2007 after a review of 69 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Emcision , Ltd. devices

FDA 510(k) Submission Details - K071103

510(k) Number K071103 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 2007
Decision Date June 27, 2007
Days to Decision 69 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 115d · This submission: 69d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

GEI Device Classification - Class 2, Special Controls

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
MORTEN SIMON CHRISTENSEN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 2093
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K071103.
PORTRAIT PSR
K071786 · Rhytec Incorporated · Jul 2007
MODIFICATION TO: ENSEAL PTC TISSUE SEALING DEVICE
K071728 · Surgrx, Inc. · Jul 2007
HALO360' COAGULATION CATHETER
K071543 · Barrx Medical, Incorporated · Jun 2007
THERMAGE THERMACOOL SYSTEM
K052936 · Thermage, Inc. · Jun 2007
EMF PAL II MAIN GENERATOR AND IRRIGATION UNITS AND ACCESSORIES
K062171 · Ortho Development Corp. · May 2007
STRYKER RF INTRADISCAL ADAPTOR, MODEL 406-750
K063480 · Stryker Corp. · May 2007

FDA 510(k) Resources - General & Plastic Surgery

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.